CALBIO 2013: 'Success Redefined' by Abraxis founder, biotech innovator Patrick Soon-Shiong
This article was originally published in Scrip
Executive Summary
Biotechnology innovator Patrick-Soon Shiong has made headlines, at least in his Southern California home base, for investments in sports teams and entertainment companies ever since the richest man in Los Angeles sold Abraxis Bioscience to Celgene for $2.9 billion, but years before that deal he began working on a plan for various integrated health care ventures.